Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 114, Issue 3, Pages 639-649Publisher
WILEY
DOI: 10.1002/jcb.24406
Keywords
INSULIN RECEPTOR; DIABETIC NEPHROPATHY; HUMAN KIDNEY; PROXIMAL TUBULE; GLUCONEOGENESIS
Categories
Funding
- Fondo Nacional de Investigacion Cientifica y Tecnologica (FONDECYT) [1090694, 3120144]
- MINECO [SAF2010-21682]
- CONICyT-Chile
- Fundacion Marcelino Botin-Espana
Ask authors/readers for more resources
Diabetes is the major cause of end stage renal disease, and tubular alterations are now considered to participate in the development and progression of diabetic nephropathy (DN). Here, we report for the first time that expression of the insulin receptor (IR) in human kidney is altered during diabetes. We detected a strong expression in proximal and distal tubules from human renal cortex, and a significant reduction in type 2 diabetic patients. Moreover, isolated proximal tubules from type 1 diabetic rat kidney showed a similar response, supporting its use as an excellent model for in vitro study of human DN. IR protein down-regulation was paralleled in proximal and distal tubules from diabetic rats, but prominent in proximal tubules from diabetic patients. A target of renal insulin signaling, the gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PEPCK), showed increased expression and activity, and localization in compartments near the apical membrane of proximal tubules, which was correlated with activation of the GSK3 beta kinase in this specific renal structure in the diabetic condition. Thus, expression of IR protein in proximal tubules from type 1 and type 2 diabetic kidney indicates that this is a common regulatory mechanism which is altered in DN, triggering enhanced gluconeogenesis regardless the etiology of the disease. J. Cell. Biochem. 114: 639649, 2013. (C) 2012 Wiley Periodicals, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available